AU2002253883A1 - Protein modification and maintenance molecules - Google Patents

Protein modification and maintenance molecules

Info

Publication number
AU2002253883A1
AU2002253883A1 AU2002253883A AU2002253883A AU2002253883A1 AU 2002253883 A1 AU2002253883 A1 AU 2002253883A1 AU 2002253883 A AU2002253883 A AU 2002253883A AU 2002253883 A AU2002253883 A AU 2002253883A AU 2002253883 A1 AU2002253883 A1 AU 2002253883A1
Authority
AU
Australia
Prior art keywords
protein modification
maintenance molecules
molecules
maintenance
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002253883A
Inventor
Chandra Arvizu
Mariah R. Baughn
Mark L. Borowski
Neil Burford
Narinder K. Chawla
Angelo M. Delegeane
Li Ding
Brendan M. Duggan
Vicki S. Elliott
Ameena R. Gandhi
Kimberly J. Gietzen
Jennifer A. Griffin
April J. A. Hafalia
Cynthia D. Honchell
Craig H. Ison
Preeti. G. Lal
Sally Lee
Dyung Aina M. Lu
Yan Lu
Jayalaxmi Ramkumar
Anita Swarnakar
Tom Y. Tang
Kavitha Thangavelu
Uyen K. Tran
Bridget A. Warren
Yuming Xu
Monique G. Yao
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2002253883A1 publication Critical patent/AU2002253883A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2002253883A 2001-01-31 2002-01-30 Protein modification and maintenance molecules Abandoned AU2002253883A1 (en)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US26570501P 2001-01-31 2001-01-31
US60/265,705 2001-01-31
US26676201P 2001-02-05 2001-02-05
US60/266,762 2001-02-05
US26958101P 2001-02-16 2001-02-16
US60/269,581 2001-02-16
US27119801P 2001-02-23 2001-02-23
US60/271,198 2001-02-23
US27281301P 2001-03-01 2001-03-01
US60/272,813 2001-03-01
US27558601P 2001-03-13 2001-03-13
US60/275,586 2001-03-13
US27850501P 2001-03-23 2001-03-23
US60/278,505 2001-03-23
US28053901P 2001-03-30 2001-03-30
US60/280,539 2001-03-30
PCT/US2002/002813 WO2002060942A2 (en) 2001-01-31 2002-01-30 Protein modification and maintenance molecules

Publications (1)

Publication Number Publication Date
AU2002253883A1 true AU2002253883A1 (en) 2002-08-12

Family

ID=27575307

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002253883A Abandoned AU2002253883A1 (en) 2001-01-31 2002-01-30 Protein modification and maintenance molecules

Country Status (5)

Country Link
EP (1) EP1356028A2 (en)
JP (1) JP2005503108A (en)
AU (1) AU2002253883A1 (en)
CA (1) CA2434953A1 (en)
WO (1) WO2002060942A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE20010121A1 (en) * 2000-02-18 2002-12-11 Hoffmann La Roche Novel Metalloproteases having Thrombospondin Domains and Nucleic Acid Compositions encoding the same
US20030170630A1 (en) * 2000-12-21 2003-09-11 Alsobrook John P. Proteins and nucleic acids encoding same
JP4251983B2 (en) 2001-06-11 2009-04-08 協和発酵キリン株式会社 Polypeptide capable of supporting proliferation or survival of hematopoietic stem cells or hematopoietic progenitor cells and DNA encoding the same
AU2002319703A1 (en) 2001-07-27 2003-02-17 Wyeth Aggrecanase molecules
CA2458818A1 (en) * 2001-08-30 2003-04-10 Nuvelo, Inc. Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
US7439332B2 (en) 2002-04-26 2008-10-21 Kirin Pharma Kabushiki Kaisha Polypeptide having an activity to support proliferation or survival of hematopoietic stem or progenitor cells
EP2093298A3 (en) * 2003-10-10 2009-09-23 Deutsches Krebsforschungszentrum Compositions for diagnosis and therapy of diseases associated with aberrant expression of Futrins (R-Spondins)
EP1824996A2 (en) * 2004-11-19 2007-08-29 Oy Jurilab Ltd Method and kit for detecting a risk of essential arterial hypertension
HUE027179T2 (en) 2006-10-20 2016-10-28 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts Rspondins as modulators of angiogenesis and vasculogenesis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1297158A2 (en) * 2000-06-21 2003-04-02 Bayer Aktiengesellschaft Regulation of human eosinophil serine protease 1-like enzyme
US20020064856A1 (en) * 2000-06-26 2002-05-30 Gregory Plowman Novel proteases

Also Published As

Publication number Publication date
WO2002060942A2 (en) 2002-08-08
WO2002060942A3 (en) 2003-07-24
CA2434953A1 (en) 2002-08-08
EP1356028A2 (en) 2003-10-29
JP2005503108A (en) 2005-02-03

Similar Documents

Publication Publication Date Title
AU2002227280A1 (en) Protein modification and maintenance molecules
AU2002258388A1 (en) Narc8 programmed cell-death-associated molecules and uses thereof
AU2002245332A1 (en) Anergy-regulated molecules
AU2002337312A1 (en) Molecules
AU2002318356A1 (en) Protein modification and maintenance molecules
AU2001270271A1 (en) Protein modification and maintenance molecules
AU2002253883A1 (en) Protein modification and maintenance molecules
AU2003300815A1 (en) Protein modification and maintenance molecules
AU2003268023A1 (en) Protein modification and maintenance molecules
AU2003205353A1 (en) Protein modification and maintenance molecules
AU2002343515A1 (en) Protein modification and maintenance molecules
AU2002327945A1 (en) Human delta-n p73 molecules and uses thereof
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2003239871A1 (en) Protein modification and maintenance molecules
AU2002336529A1 (en) Protein modification and maintenance molecules
AU2003231981A1 (en) Protein modification and maintenance molecules
AU2002258724A1 (en) Protein modification and maintenance molecules
AU2002216946A1 (en) Modified pna molecules
AU2003298589A1 (en) Protein modification and maintenance molecules
AUPR849001A0 (en) Immunointeractive molecules and uses thereof
AU2003279829A1 (en) Protein modification and maintenance molecules
AU2002357609A1 (en) Novel proteins and dnas thereof
AUPR713201A0 (en) Novel therapeutic molecules and uses therefor
AU2002323918A1 (en) Novel protein and its dna
AUPR421601A0 (en) Therapeutic molecules and methods - 1B

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase